Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 24
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Branch DR, Leger RM, Sakac d, Yi Q, Duong T, Yeung RSM, Binnington B, Bloch EM | 2022 | Blood Adv | View Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Researchers | Basic research |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Simard C, Fournier D, Pineault N, Trépanier P | 2022 | Cytotherapy | View Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Researchers | New or improved product or process |
Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs | Wang A, Ribeiro RVP, Ali A, Brambate E, Abdelnour-Berchtold E, Michaelsen V, Zhang Y, Rahfeld P, Moon H, Gokhale H, Gazzalle A, Pal P, Liu M, Waddell TK, Cserti-Gazdewich C, Tinckam K, Kizhakkedathu JN, West L, Keshavjee S, Withers SG, Cypel M | 2022 | Sci Transl Med | View Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs | Researchers | Clinical research |
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Paes B, Chan AKC, Shaik M, Patel D, Bhatt MD | 2022 | Blood Coagul Fibrinolysis | View Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Health care providers | Clinical research |
Sexual risk behavior questions: Understanding and mitigating donor discomfort | Haw J, Woo H, Kohut T, Fisher W | 2022 | Transfusion | View Sexual risk behavior questions: Understanding and mitigating donor discomfort | Blood operators | MSM research |
Preservation and Storage of Cells for Therapy: Current Applications and Protocols | Acker JP, Bondarovych M, Brunotte R, Buriak IA, Fuller BJ, Glasmacher B, Goltsev AM, Gregor J, Gryshkov O, Herrity K, Honegrová B, Hunt CJ, Jandová M, Johnstone BH, Kilbride P, Lánská M, Mann J, Měřička P, Musall KG, Mutsenko V, Mykhailova O, Petrenko Y, Radocha J, Sherry AM, Stacey GN, Štěrba L, Vokurková D, William N, Woods EJ | 2022 | Cell Engineering and Regeneration | View Preservation and Storage of Cells for Therapy: Current Applications and Protocols | Researchers | Benchmarking and standard setting |
FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Bodnar M, Bienz M, Clarke G | 2022 | Blood.ca website | View FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Health care providers | New or improved product or process |
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A, Landry D, La Rocca U, Lemyre B, Maier RF, Muniz-Diaz E, Nahirniak S, New HV, Pavenski K, Dos Santos MCP, Ramsey G, Shehata N, International Collaboration for Transfusion Medicine Guidelines | 2022 | Brit J Haem | View International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Health care providers | Benchmarking and standard setting |
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Woo H | 2022 | Blood.ca website | View ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Blood operators | MSM research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
The response of a human haematopoietic cell line to trehalose-loaded liposomes and their effect on post-thaw membrane integrity | Scott KL, William N, Acker JP | 2022 | Cryobiology | View The response of a human haematopoietic cell line to trehalose-loaded liposomes and their effect on post-thaw membrane integrity | Researchers | Basic research |
Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, Rangarajan S, Karampatos S, Leong DP, Hillis CM | 2022 | Leuk Res | View Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Researchers | Clinical research |
Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Chi SI, Kumaran D, Zeller MP, Ramirez-Arcos S | 2022 | Annals of Blood | View Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Health care providers | Clinical research |
Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Grunau B, Tom J, Asamoah-Boaheng M, O’Brien SF, Drews SJ, Sediqi S, Lavoie PM, Barakauskas V, Goldfarb DM | 2022 | Open Forum Infect Dis | View Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Researchers | Basic research |
Emicizumab state-of-the-art update | Mahlangu J, Iorio A, Kenet G | 2022 | Haemophilia | View Emicizumab state-of-the-art update | Health care providers | Clinical research |
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Sheffield WP, Bhakta V, Howell A, Jenkins C, Serrano K, Johnson N, Lin Y-CJ, Colwill K, Rathod B, Greenberg B, Gingras A-C, Evans DH, Flaumenhaft E, Beckett A, Drews SJ, Devine DV | 2022 | Transfusion | View Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Researchers | Basic research |
Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage | Murru A, Allard M-È, Paré G, Vaillancourt M, Boyer L, Cayer M-P, Vitry J, Landry P, Labrecque M-M, Robitaille N, Branch DR, Girard M, Fernandes MJ | 2022 | Front Med | View Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage | Researchers | Basic research |
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 | Grunau B, Golding L, Prusinkiewicz MA, Asamoah-Boaheng M, Armour R, Marquez AC, Jassem AN, Barakauskas V, O’Brien SF, Drews SJ, Haig S, Lavoie PM, Goldfarb DM | 2022 | Microbiol Spectr | View Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 | Researchers | Clinical research |
The impact of donor ferritin testing on blood availability in Canada | Blake JT, O'Brien SF, Goldman M | 2022 | Vox Sang | View The impact of donor ferritin testing on blood availability in Canada | Blood operators | New or improved product or process |
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Batarfi K | 2021 | Blood.ca website | View ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Researchers | Clinical research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Viana R, D'Alessio D, Grant L, Cooper N, Arnold D, Morgan M, Provan D, Cuker A, Hill QA, Tomiyama Y, Ghanima W | 2021 | Adv Ther | View Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Researchers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Branch DR, Sandhu G, Raos M | 2021 | Transfusion | View Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Researchers | New or improved product or process |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
Themed issue – focusing on donor assessment, motivation and vigilance | O’Brien SF, Ullum H, Seed CR | 2021 | Vox Sang | View Themed issue – focusing on donor assessment, motivation and vigilance | Researchers | New or improved product or process |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Haemophilia | View Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Researchers | Clinical research |
Challenging the 30-min rule for thawed plasma | Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W | 2021 | Vox Sang | View Challenging the 30-min rule for thawed plasma | Researchers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
How do I think about blood donor eligibility criteria for medical conditions? | Goldman M | 2021 | Transfusion | View How do I think about blood donor eligibility criteria for medical conditions? | Researchers | Benchmarking and standard setting |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed C, Steele W, Davidson K, Custer B, O’Brien S, Assessment ObotSR, Policy sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2021 | medRxiv | View Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Kapopara PR, Safikhan NS, Huang JL, Meixner SC, Gonzalez K, Loghmani H, Ruf W, Mast AE, Lei V, Pryzdial ELG, Conway EM | 2021 | J Thromb Haemost | View CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |